EyePoint (EYPT) Non-Current Debt (2018 - 2023)
EyePoint (EYPT) reported Non-Current Debt of $29.4 million for Q1 2023, up 0.9% on a YoY basis from $29.1 million in Q1 2022, and little changed sequentially from $29.3 million in Q4 2022.
EyePoint (EYPT) Non-Current Debt (2018 - 2023) Analysis & Trends
EyePoint (EYPT) has 6 years of Non-Current Debt data on file, last reported at $29.4 million in Q1 2023.
- For the quarter ending Q1 2023, Non-Current Debt rose 0.9% year-over-year to $29.4 million; the trailing twelve-month figure through Mar 2023 stood at $29.4 million (up 0.9% YoY), and the FY2022 full-year result was $29.3 million, down 19.83% from the prior year.
- Non-Current Debt held at $29.4 million in Q1 2023, from $29.3 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $50.8 million in Q3 2020 to a low of $29.1 million in Q1 2022.
- A 5-year average of $38.4 million and a median of $36.6 million in 2021 frame the typical range for Non-Current Debt.
- Across the five-year window, Non-Current Debt surged 167.99% in 2019 and declined 28.32% in 2021, its largest moves.
- Tracing EYPT's Non-Current Debt over 5 years: stood at $47.2 million in 2019, then decreased by 19.58% to $38.0 million in 2020, then retreated by 3.73% to $36.6 million in 2021, then declined by 19.83% to $29.3 million in 2022, then grew by 0.2% to $29.4 million in 2023.
- Business Quant data shows EYPT's Non-Current Debt at $29.4 million in Q1 2023, $29.3 million in Q4 2022, and $29.3 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 29.37 Mn |
| Dec 31, 2022 | 29.31 Mn |
| Sep 30, 2022 | 29.25 Mn |
| Jun 30, 2022 | 29.18 Mn |
| Mar 31, 2022 | 29.11 Mn |
| Dec 31, 2021 | 36.56 Mn |
| Sep 30, 2021 | 36.40 Mn |
| Jun 30, 2021 | 36.24 Mn |
| Mar 31, 2021 | 38.12 Mn |
| Dec 31, 2020 | 37.98 Mn |
| Sep 30, 2020 | 50.78 Mn |
| Jun 30, 2020 | 50.26 Mn |
| Mar 31, 2020 | 47.72 Mn |
| Dec 31, 2019 | 47.22 Mn |
| Sep 30, 2019 | 46.73 Mn |
| Jun 30, 2019 | 46.25 Mn |
| Mar 31, 2019 | 31.95 Mn |
| Dec 31, 2018 | 17.62 Mn |
| Sep 30, 2018 | 17.46 Mn |
| Jun 30, 2018 | 17.31 Mn |